These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29796293)

  • 1. Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial.
    Lannin NA; Ada L; Levy T; English C; Ratcliffe J; Sindhusake D; Crotty M
    Pilot Feasibility Stud; 2018; 4():82. PubMed ID: 29796293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Crotty M
    Int J Stroke; 2018 Aug; 13(6):648-653. PubMed ID: 29553309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: the InTENSE randomised trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Faux S; Palit M; Gonzalez S; Olver J; Schneider E; Crotty M; Cameron ID
    BMC Neurol; 2022 Apr; 22(1):154. PubMed ID: 35468766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Faux SG; Palit M; Gonzalez S; Olver J; Cameron I; Crotty M;
    Stroke; 2020 Feb; 51(2):556-562. PubMed ID: 31813359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Rodgers H; Shaw L; Price C; van Wijck F; Barnes M; Graham L; Ford G; Shackley P; Steen N;
    Trials; 2008 Oct; 9():59. PubMed ID: 18947418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different frequencies of repetitive transcranial magnetic stimulation combined with local injection of botulinum toxin type A for post-stroke lower limb spasticity: study protocol for a prospective, single-center, non-randomized, controlled clinical trial.
    Shao Y; Yang Y; Sun YX; Xu AH
    Neural Regen Res; 2022 Nov; 17(11):2491-2496. PubMed ID: 35535901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M; Gorelik A; Louie J; Brand C; Baguley IJ; Khan F
    J Rehabil Med; 2014 Sep; 46(8):730-7. PubMed ID: 25073939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dynamic lycra orthosis as an adjunct to rehabilitation after botulinum toxin-A injection of the upper-limb in adults following stroke: A single-blinded randomized controlled pilot study.
    Giray E; Gencer Atalay K; Eren N; Gündüz OH; Karadag-Saygi E
    Top Stroke Rehabil; 2020 Sep; 27(6):473-481. PubMed ID: 31868130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
    Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
    J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M; Brand C; Louie J; Khan F
    J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
    Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
    Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: a randomized double-blind controlled trial.
    Im S; Park JH; Son SK; Shin JE; Cho SH; Park GY
    Clin Rehabil; 2014 Jun; 28(6):604-13. PubMed ID: 24452704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.